PUR-WASH- eyewash solution 
Niagara Pharmaceuticals, Inc.

----------

Niagara Pur-Wash

Active ingredient

Purified water 98.3%

Purpose

Eyewash

Warnings

For external use only

Do not use

When using this product

Use

For cleansing the eye to help relieve irritation or burning by removing loose foreign material

Stop use and ask a doctor if you have any of the following

Keep out of reach of children

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other information

Inactive ingredients

boric acid, sodium borate, sodium chloride

Questions?

☎ Call 973-227-1830 9 a.m. to 5 p.m. EST Mon-Fri

Dosage and Administration

Warnings

For external use only

Package Label.Principal Display Panel

PDP

PUR-WASH 
eyewash solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:65785-168
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
WATER (UNII: 059QF0KO0R) (WATER - UNII:059QF0KO0R) WATER465 mL  in 473 mL
Inactive Ingredients
Ingredient NameStrength
BORIC ACID (UNII: R57ZHV85D4)  
SODIUM BORATE (UNII: 91MBZ8H3QO)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:65785-168-01473 mL in 1 BOTTLE, UNIT-DOSE; Type 0: Not a Combination Product09/01/2015
2NDC:65785-168-02946 mL in 1 BOTTLE, UNIT-DOSE; Type 0: Not a Combination Product09/01/2015
Image of Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02230501/30/2015
Labeler - Niagara Pharmaceuticals, Inc. (205477792)
Registrant - Niagara Pharmaceuticals, Inc. (205477792)
Establishment
NameAddressID/FEIBusiness Operations
Niagara Pharmaceuticals, Inc.205477792manufacture(65785-168)

Revised: 3/2023
Document Id: f68dfd2b-34e9-ad12-e053-2a95a90a54f4
Set id: 0d43b1c1-2699-37f1-e054-00144ff88e88
Version: 8
Effective Time: 20230310
 
Niagara Pharmaceuticals, Inc.